title: Proteomic Characterization of Cerebrospinal Fluid from Ataxia-Telangiectasia (A-T) Patients Using a LC/MS-Based Label-Free Protein Quantification Technology.
abstract: Cerebrospinal fluid (CSF) has been used for biomarker discovery of neurodegenerative diseases in humans since biological changes in the brain can be seen in this biofluid. Inactivation of A-T-mutated protein (ATM), a multifunctional protein kinase, is responsible for A-T, yet biochemical studies have not succeeded in conclusively identifying the molecular mechanism(s) underlying the neurodegeneration seen in A-T patients or the proteins that can be used as biomarkers for neurologic assessment of A-T or as potential therapeutic targets. In this study, we applied a high-throughput LC/MS-based label-free protein quantification technology to quantitatively characterize the proteins in CSF samples in order to identify differentially expressed proteins that can serve as potential biomarker candidates for A-T. Among 204 identified CSF proteins with high peptide-identification confidence, thirteen showed significant protein expression changes. Bioinformatic analysis revealed that these 13 proteins are either involved in neurodegenerative disorders or cancer. Future molecular and functional characterization of these proteins would provide more insights into the potential therapeutic targets for the treatment of A-T and the biomarkers that can be used to monitor or predict A-T disease progression. Clinical validation studies are required before any of these proteins can be developed into clinically useful biomarkers.
authors.affiliation: Department Biochemistry and Molecular Biology, Indiana University School of Medicine, 635 Barnhill Dr., MS 4053, Indianapolis, IN 46202, USA.
authors.forename: Monika
authors.initials: M
authors.lastname: Dzieciatkowska
authors.forename: Guihong
authors.initials: G
authors.lastname: Qi
authors.forename: Jinsam
authors.initials: J
authors.lastname: You
authors.forename: Kerry G
authors.initials: KG
authors.lastname: Bemis
authors.forename: Heather
authors.initials: H
authors.lastname: Sahm
authors.forename: Howard M
authors.initials: HM
authors.lastname: Lederman
authors.forename: Thomas O
authors.initials: TO
authors.lastname: Crawford
authors.forename: Lawrence M
authors.initials: LM
authors.lastname: Gelbert
authors.forename: Cynthia
authors.initials: C
authors.lastname: Rothblum-Oviatt
authors.forename: Mu
authors.initials: M
authors.lastname: Wang
references.citation: Nat Rev Mol Cell Biol. 2000 Dec;1(3):179-86
references.pmid: 11252893
references.citation: Cancer Biol Ther. 2007 Mar;6(3):354-9
references.pmid: 17312390
references.citation: Regul Pept. 2009 Jan 8;152(1-3):13-21
references.pmid: 18721831
references.citation: Nat Rev Cancer. 2003 Mar;3(3):155-68
references.pmid: 12612651
references.citation: Peptides. 1995;16(6):1097-107
references.pmid: 8532594
references.citation: Pharmacol Biochem Behav. 2009 Apr;92(2):304-13
references.pmid: 19166871
references.citation: Brief Funct Genomic Proteomic. 2005 May;4(1):27-38
references.pmid: 15975262
references.citation: Clin Cancer Res. 2004 Oct 15;10(20):6789-95
references.pmid: 15501955
references.citation: J Neurosci. 2009 Oct 21;29(42):13377-88
references.pmid: 19846725
references.citation: J Proteomics. 2011 Apr 1;74(4):371-88
references.pmid: 21111852
references.citation: J Endocrinol. 1999 Jun;161(3):475-84
references.pmid: 10333550
references.citation: Proteomics Clin Appl. 2007 Mar;1(3):246-63
references.pmid: 21136676
references.citation: Anal Chem. 2002 Apr 1;74(7):1650-7
references.pmid: 12043600
references.citation: PLoS One. 2009;4(2):e4430
references.pmid: 19221597
references.citation: Science. 2010 Oct 22;330(6003):517-21
references.pmid: 20966255
references.citation: Nat Rev Neurol. 2010 Mar;6(3):131-44
references.pmid: 20157306
references.citation: Anal Biochem. 1976 May 7;72:248-54
references.pmid: 942051
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15539-44
references.pmid: 16223874
references.citation: Radiother Oncol. 2005 Aug;76(2):112-8
references.pmid: 16026874
references.citation: Mol Cell Biol. 2010 Feb;30(4):1059-66
references.pmid: 19995905
references.citation: Nat Immunol. 2008 Feb;9(2):137-45
references.pmid: 18157132
references.citation: Dis Markers. 2002;18(2):99-105
references.pmid: 12364816
references.citation: Cancer Invest. 2009 Oct;27(8):844-50
references.pmid: 19626493
references.citation: Mol Genet Metab. 2003 Dec;80(4):437-43
references.pmid: 14654357
references.citation: Neuron. 1991 Aug;7(2):209-20
references.pmid: 1873027
references.citation: Science. 1995 Jun 23;268(5218):1749-53
references.pmid: 7792600
references.citation: J Neurochem. 2010 Mar;112(6):1386-414
references.pmid: 20050976
references.citation: Transl Res. 2008 Mar;151(3):122-8
references.pmid: 18279810
references.citation: Semin Pediatr Neurol. 2003 Sep;10(3):173-82
references.pmid: 14653405
references.citation: Nat Biotechnol. 2001 Mar;19(3):242-7
references.pmid: 11231557
references.citation: Regul Pept. 2008 Jun 5;148(1-3):95-8
references.pmid: 18448176
references.citation: Cell Death Differ. 2007 Sep;14(9):1700-10
references.pmid: 17599100
references.citation: Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5360-70
references.pmid: 18055782
references.citation: EMBO J. 2003 Oct 15;22(20):5612-21
references.pmid: 14532133
references.citation: J Clin Invest. 2008 Jan;118(1):133-48
references.pmid: 18079966
references.citation: Neuroscience. 1996 Jun;72(4):1023-36
references.pmid: 8735227
references.citation: Pediatrics. 1958 Apr;21(4):526-54
references.pmid: 13542097
references.citation: Nat Biotechnol. 1999 Oct;17(10):994-9
references.pmid: 10504701
references.citation: Anal Biochem. 2004 Oct 1;333(1):174-81
references.pmid: 15351294
references.citation: Brief Funct Genomic Proteomic. 2008 Sep;7(5):329-39
references.pmid: 18579615
references.citation: Cell Immunol. 1999 Jan 10;191(1):34-48
references.pmid: 9918685
references.citation: Nat Biotechnol. 2003 May;21(5):532-8
references.pmid: 12692561
references.citation: Br J Cancer. 2009 Aug 4;101(3):457-64
references.pmid: 19603023
references.citation: Genes Dev. 2000 Apr 15;14(8):927-39
references.pmid: 10783165
references.citation: Neurology. 2006 Apr 25;66(8):1218-22
references.pmid: 16481598
references.citation: Neurochem Res. 1998 Aug;23(8):1117-23
references.pmid: 9704602
references.citation: Proteomics Clin Appl. 2009 Nov;3(11):1305-13
references.pmid: 21136952
references.citation: Exp Dermatol. 2007 Nov;16(11):881-90
references.pmid: 17927570
references.citation: Mol Cell Proteomics. 2009 May;8(5):946-58
references.pmid: 19164277
references.citation: Cancer Invest. 2008 May;26(4):375-84
references.pmid: 18443958
references.citation: Bioinformatics. 2003 Jan 22;19(2):185-93
references.pmid: 12538238
references.citation: J Proteome Res. 2005 Jul-Aug;4(4):1442-50
references.pmid: 16083298
references.citation: Brain. 2009 Mar;132(Pt 3):810-9
references.pmid: 19201763
references.citation: Brain Res. 1995 Apr 3;676(1):69-79
references.pmid: 7796180
references.citation: J Proteome Res. 2011 May 6;10(5):2651-7
references.pmid: 21322649
references.citation: J Proteome Res. 2007 May;6(5):1758-67
references.pmid: 17397207
references.citation: Medicine (Baltimore). 1991 Mar;70(2):99-117
references.pmid: 2005780
references.citation: Brain Res Mol Brain Res. 1994 Jul;24(1-4):11-9
references.pmid: 7968348
references.citation: Anal Bioanal Chem. 2007 Oct;389(4):1017-31
references.pmid: 17668192